Suzhou Pengxu Pharmaceutical Technology Co., Ltd., established on 2011-07-07, Business scope includes research and development of pharmaceutical intermediates,Sales;API,new medical research;new material technology,biomedical technology,Software technology research and development,consult,Services and Transfers;Chemical product sales(Excluding hazardous chemicals),Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(The above related licenses can only be operated after obtaining the license)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Suzhou Jingyun Pharmaceutical Technology Co., Ltd., established on 2010-07-21, Business scope includes technology research and development in the field of biopharmaceuticals,Technical Services,technical consulting,technology transfer;chemical product,Pharmaceutical Intermediates,API R&D,test,Sales;Import of required raw materials and equipment and export of chemical products and raw materials.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zentiva ks specializes in the development, manufacture and marketing of generic pharmaceutical products. It offers generic drugs, over the counter medicines, dietary supplements, cosmetics and pharmaceutical substances. The company's products cover therapy areas of cardiovascular disease, pain, alimentary, genitourinary tract diseases, inflammations and central nervous system diseases including digestive problems. Zentiva was founded in 1989 and is headquartered in Prague, Czech Republic.

Zhejiang Huahai Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products. It also integrates and intermediates formulations such as Active Pharmaceutical Ingredients. Its products include Irbesartan and Hydrochlorothiazide Tablet, Paroxetine Hydrochloride Tablet and Irbesartan Tablet. The company was founded in 1989 and is headquartered in Zhejiang, China.

Apotex is a Canadian owned pharmaceutical company, and the largest producer of generic medicines in the country. Founded in 1974, the company has focused on research, development, manufacturing and distribution. Apotex has steadily grown to employ over 10,000 people around the world. Apotex Pharmachem is a global, fully integrated API R&D and manufacturing organization with its headquarters located in Brantford, Ontario, and is a member of the Apotex group of companies. Apotex Pharmachem has multiple facilities around the world located in Canada, India, Mexico, and China. Learn more at www.ApotexPharmachem.com.

Shanghai Aobo Biomedical Co., Ltd., established on 2004-06-11, Business scope includes general items:engaged in biotechnology,Technology development in the field of medical technology expertise,technology transfer,technical consulting,Technical Services,Technology Exchange,Technology Promotion;Medical Research and Experimental Development;Specialty Chemicals Sales(Free of Hazardous Chemicals);R&D of industrial enzyme preparations;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Up to now, the company has a registered capital of 725 million yuan, total assets of 5.3 billion yuan and net assets of 3.6 billion yuan. The company has more than 2,900 employees, including more than 230 masters.The company has two headquarters in Xinchang and Hangzhou. It has six production sites including the plant in Xinchang for finished medicines, the two API plants in Shangyu and Shangrao, the TCM production site in Bayannaoer, Inner Mongolia, and the medical equipment production base of Shenzhen and Shenyang. Aside from that, the company also owns a breeding base in Yunnan. In Shanghai, the company has established its own research institute i n the Zhangjiang Hi-Tech Park. Joint ventures and collaberated labs have also been founded over the years in the U.S.A., the U.K., Denmark, Isereal, Korea as well as other countries.

Part of Zhejiang Jingxin Pharmaceutical Co., Ltd., Shanghai Jingxin Biopharmaceutical Co. Ltd. is a Chinese company located in Shanghai that manufactures and distributes biopharmaceutical materials. The firm was acquired by Zhejiang Jingxin Pharmaceutical Co., Ltd. on August 08, 2011 for $3.75 million.

Suzhou Kaixiang Biotechnology Co., Ltd., established on 2010-12-03, The scope of business includes biological fields and instruments,food additives,Technical development of plant extracts and active ingredients,technology transfer,Technical consulting and related technical services;cosmetic,Chemical raw materials and products(In addition to dangerous goods),Instrument purchase and sale;Self-operated and agent import and export business of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:food business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Beijing Xinkaiyuan Pharmaceutical Technology Co., Ltd., established on 2014-03-20, Business scope includes biotechnology promotion;Medical Research;technology development;technical consulting;technology transfer;Import and export,Technology Import and Export,Agent import and export.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policy of the district.)

Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE.

Tianjin Institute of Pharmaceutical Research Co., Ltd. engages in the in the development of various new products such as innovative drugs, generic drugs, new preparations, traditional Chinese medicines, and biological drugs with particular emphasis on the engineering and industrialization of new technologies to meet drug registration requirements. The company was founded in 1959 and is headquartered in Tianjin, China.

Zhejiang Huahai Pharmaceutical Co., Ltd. Shanghai Branch, established on 2004-04-22, The scope of business includes import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Hainan Xinkaiyuan Pharmaceutical Technology Co., Ltd., established on 2020-03-20, Business scope includes licensed projects:Inspection and testing service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Biochemical product technology research and development;Specialty Chemicals Sales(Free of Hazardous Chemicals)(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

China Resources Saike Pharmaceutical Co., Ltd., part of China Resources Double-Crane Pharmaceutical Co., Ltd., is a Chinese company located in Beijing. The firm manufactures pharmaceutical products. It was founded in 1981. China Resources Double-Crane Pharmaceutical Co., Ltd. acquired China Resources Saike Pharmaceutical Co., Ltd. from Beijing Pharmaceutical Group Co., Ltd. on November 30, 2015 for $624.11 million.

Baiyu produces pharmaceutical products. Their products include ginkgolide injection, enoxaparin sodium injection, lansoprazole, anticoagulant drugs, digestive drugs, and others. They provide research and development, wholesale, and retail services.

Jiangsu Wanbang Biopharmaceuticals Co., Ltd. engages in the manufacture of biopharmaceutical products. Its products include insulin, febuxostate tablets, heparin sodium, endocrine products, cardiovascular products, biochemical products, Chinese medicine, and Chinese herbal powders. The company was founded in 1974 and is headquartered in Xuzhou, China.

Jiangxi Synergy Pharmaceutical Co., Ltd. engages in the research and development, production and sale of chemical raw materials, active pharmaceutical ingredient and pharmaceutical intermediates. Its products includes anti-epileptic medicines, anti-ulcer medicines, anti-pyretic analgesics, non-steroid anti-inflammatory analgesics, anti-high blood pressure medicines and anti-depression drugs. The company was founded on April 20, 2004 and is headquartered in Yichun, China.

Beijing Fukangren Biopharmaceutical Technology Co., Ltd., established on 2002-03-01, Business scope includes technology development;technology transfer;technical consulting;Technical Services;Import and export;Sales of medical devices Class I,cosmetic;sell food;production of medicines(Manufacture of new chemical preparations is restricted).(Market entities independently choose business projects in accordance with the law,Carry out business activities;sell food,Production of pharmaceuticals and projects subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)